Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
From licensing, to clinical trials, to competitor activity – you’ll stay up to date on news worldwide thanks to our global team of 60+ journalists. We go beyond headlines too, with access to key decision-makers and best-in-class proprietary data.
How it works
You’ll get business-critical market and company intelligence from our network of analysts, journalists and key opinion leaders. They cover companies from biotech start-ups to multinational giants such as Pfizer, Sanofi and Shire, and fields including cancer, cardiovascular, diabetes, dermatology, influenza and oncology.
How Scrip can help
Understand what’s behind the headlines – we focus on the strategic implications of global pharma news so you can see what developments mean for your business.
Scrips global team of journalists span key markets around the clock
Get exclusive access to accurate data, timely insights and trusted analysis that delivers to gain competitive advantage
Access interviews with leading decision makers, industry experts and thought leaders, across the industry.
Put your questions about any of our news stories, data and analysis to our expert journalists and analysts.
Scrip
By Lucie Ellis 27 Jul 2017
In her first address as CEO, Emma Walmsley has shocked the market with a long list of changes for GSK, including a total makeover of the group's pharma unit. As a result, more than 30 R&D programs will be getting the axe and a 2011 commercialization partnership with Johnson & Johnson is on its way to the gallows.
Topic Business strategies
Scrip
By Lucie Ellis 27 Jul 2017
Leading immunotherapy agents are beginning to report early-stage data from monotherapy and combination trials in advanced cervical cancer – a treatment area with very few approved options.
Scrip
By Kevin Grogan 26 Jul 2017
Having become embroiled in a legal tussle with Roche last week concerning the latter's emicizumab, Shire has licensed a hemophilia A bispecific monoclonal antibody of its own.
Topic Research
Scrip
25 Jul 2017
As PD-1 inhibitors march toward earlier-stage head and neck cancers, researchers consider ways to improve the precision of immunotherapy through better patient selection and combinations for this accessible tumor type.
Topic Cancer immuno-oncology
Scrip
25 Jul 2017
Merck & Co. launched Renflexis in the US, marking the first time two biosimilars will compete for share against a brand, in this case J&J's Remicade.
Topic Biosimilars
Scrip
By Kevin Grogan 21 Jul 2017
While the rumor mill continues to turn over Pascal Soriot jumping ship from AstraZeneca to Teva.
Scrip
By Eleanor Malone 21 Jul 2017
Last week, AstraZeneca's CEO Pascal Soriot was rumored to be preparing for a move to run Teva Pharmaceutical Industries. This week, he's rumored to be staying put.
Scrip
By Mandy Jackson 21 Jul 2017
A legal settlement with BioMarin means that Sarepta doesn't have to worry anymore.
Scrip
By Anju Ghangurde 18 Jul 2017
Digital physician engagement channels appear to be closing in on the traditional face-to-face approach.
Scrip
By Sten Stovall 18 Jul 2017
Datamonitor Healthcare's latest sector analysis indicates that the pharma industry's 10 biggest companies.
Scrip
By Lucie Ellis 11 Jul 2017
Ten clinical trial data readouts to watch for in the third quarter of 2017.
Topic Clinical trials
Scrip
By Jung Won Shin 11 Jul 2017
While rising dementia populations are a worldwide problem, South Korea has to pay particularly close attention.
Scrip
By Emily Hayes 05 Jul 2017
Strategy of focusing immunotherapy on urologists and earlier stage prostate cancer is paying off, says CEO James Caggiano.
Scrip
By Joseph Haas 05 Jul 2017
Trying to catch up with peers in both immuno-oncology and NASH, the German pharma has assigned Sapountzis to lead its US business development efforts.
Topic Cancer immuno-oncology
Scrip
27 Jun 2017
BIO International 2017 discussion: growing a biotech business.
Topic Business strategies
Scrip
26 Jul 2017
Scrip
26 Jul 2017
Scrip
26 Jul 2017
Scrip
26 Jul 2017
Scrip
26 Jul 2017
Scrip
26 Jul 2017
Scrip
26 Jul 2017
Scrip
26 Jul 2017
Scrip
26 Jul 2017
Scrip
25 Jul 2017
Scrip
25 Jul 2017
Scrip
25 Jul 2017
Scrip
25 Jul 2017
Scrip
25 Jul 2017
Scrip
25 Jul 2017
Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions. Its accurate and objective drug sales forecasts and segmented patient based disease forecasts are continually updated in reaction to key changes in the market, ensuring decisions are always based on the current reality of the market place.
From discovery to patent expiry, and coverage spanning both ethical and generic drugs, Medtrack has you covered. Stay current on key financing, drug and biologics development and drug manufacturing information, all with a single tool.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Looking for more products Product Finder
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Report store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
